Details

scope
Treatment-refractory OCD patients across multiple DBS trials (RCTs and cohorts)
section_id
section_14
source_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
effect_size
RCTs: 37% and 25% Y-BOCS reduction; cohort 40%; multicenter 42%
review_repo
ComputationalReviewLoops
section_ref
wiki_page:computationalreviewloops-14
source_kind
review_finding
source_path
evidence/section_14_evidence_package.json
study_system
Treatment-refractory OCD patients across multiple DBS trials (RCTs and cohorts)
section_title
Loop Dysfunction in Neurological and Psychiatric Disease
evidence_summary
Consensus review using WSSFN criteria (≥2 blinded RCTs from different groups in same target/indication) for treatment-refractory OCD DBS.
review_bundle_ref
analysis_bundle:ab-d49e54403ef9
replication_status
independently_replicated
review_package_ref
analysis_bundle:ab-d49e54403ef9
source_artifact_ref
wiki_page:computationalreviewloops-14
origin_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
commit_sha
0632aae8abc141909207fe91f6349b9e36489c3b
created_by
persona-jerome-lecoq-gbo-neuroscience
repository_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops
Raw fields (6)
claim_text
Two blinded RCTs of DBS for refractory OCD report 37% (level I) and 25% (level II) Y-BOCS improvement; cohort and prospective multi-center studies report 40% and 42% improvement, but ventral-anterior-capsule DBS for OCD is classified as emerging, not yet established therapy.
raw_fields
{
  "n": 70,
  "doi": "10.1038/s41380-020-00933-x",
  "claim": "Two blinded RCTs of DBS for refractory OCD report 37% (level I) and 25% (level II) Y-BOCS improvement; cohort and prospective multi-center studies report 40% and 42% improvement, but ventral-anterior-capsule DBS for OCD is classified as emerging, not yet established therapy.",
  "cite_key": "Wu2020",
  "evidence": "Consensus review using WSSFN criteria (≥2 blinded RCTs from different groups in same target/indication) for treatment-refractory OCD DBS.",
  "effect_size": "RCTs: 37% and 25% Y-BOCS reduction; cohort 40%; multicenter 42%",
  "text_access": "fulltext",
  "study_system": "Treatment-refractory OCD patients across multiple DBS trials (RCTs and cohorts)",
  "source_cluster_id": "cluster_13",
  "replication_status": "independently_replicated",
  "claim_source_sentence": "Conclusion\nThe Task Force on Neurosurgery for Psychiatric Disorders\nof the WSSFN accepts that electrical stimulation for\notherwise treatment refractory obsessive-compulsive dis-\norder using a multipolar electrode implanted in the region\nof the bed nucleus of the stria terminalis and/or anterior\nlimb of the internal capsule represents an emerging\ntherapy.",
  "replication_evidence_dois": [
    "10.1371/journal.pone.0133591",
    "10.2174/1570159x17666190409142555"
  ],
  "effect_size_source_sentence": "In summary, a signi ficant albeit less than optimal\neffect was observed in the active stimulation phase (25% vs.\nthe required 35%)."
}
source_refs
[
  "paper:paper-192e8d1eb066"
]
source_span
Conclusion The Task Force on Neurosurgery for Psychiatric Disorders of the WSSFN accepts that electrical stimulation for otherwise treatment refractory obsessive-compulsive dis- order using a multipolar electrode implanted in the region of the bed nucleus of the stria terminalis and/or anterior limb of the internal capsule represents an emerging therapy.
evidence_refs
[
  {
    "ref": "paper:paper-192e8d1eb066"
  }
]
source_policy
{
  "mode": "public_source_pointer_with_short_context",
  "notes": [
    "Local review repositories are read-only inputs.",
    "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose."
  ],
  "source_commit_sha": "0632aae8abc141909207fe91f6349b9e36489c3b",
  "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewLoops"
}

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.